5 Trends That Will Shape U.S. IVD Market by 2019 U.S. IVD Market | Page 4

Key Benefits
• The reagent segment dominated the market in 2016, and is projected to grow at
the 2.9% CAGR.
• The immunodiagnostics segment accounted for the highest share in 2016.
• The infectious diseases segment was the major shareholder in the market in 2016.
• The standalone laboratory segment accounted for the highest share in 2016.